The Global Resource For Connecting Buyers and Sellers

Data on Cancer Resistance Pathway Inhibitor IT-139 to be Presented at AACR 2018 Annual Meeting

TAMPA, Fla., March 22, 2018 /PRNewswire/ — Intezyne, a clinical-stage biopharmaceutical company focused on developing novel cancer therapies, announced that Ayesha Shajahan-Haq, PhD, Assistant Professor of Oncology at the Georgetown Lombardi Comprehensive Cancer Center at Georgetown…